441 related articles for article (PubMed ID: 29574915)
1. Cyclophosphamide versus etoposide in combination with total body irradiation as conditioning regimen for adult patients with Ph-negative acute lymphoblastic leukemia undergoing allogeneic stem cell transplant: On behalf of the ALWP of the European Society for Blood and Marrow Transplantation.
Czyz A; Labopin M; Giebel S; Socié G; Apperley J; Volin L; Reményi P; Yakoub-Agha I; Orchard K; Michallet M; Stuhler G; Chaganti S; Murray M; Aljurf M; Bloor A; Passweg J; Finke J; Mohty M; Nagler A
Am J Hematol; 2018 Jun; 93(6):778-785. PubMed ID: 29574915
[TBL] [Abstract][Full Text] [Related]
2. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
[TBL] [Abstract][Full Text] [Related]
3. Comparison of Cyclophosphamide Combined with Total Body Irradiation, Oral Busulfan, or Intravenous Busulfan for Allogeneic Hematopoietic Cell Transplantation in Adults with Acute Lymphoblastic Leukemia.
Mitsuhashi K; Kako S; Shigematsu A; Atsuta Y; Doki N; Fukuda T; Kanamori H; Onizuka M; Takahashi S; Ozawa Y; Kurokawa M; Inoue Y; Nagamura-Inoue T; Morishima Y; Mizuta S; Tanaka J;
Biol Blood Marrow Transplant; 2016 Dec; 22(12):2194-2200. PubMed ID: 27638362
[TBL] [Abstract][Full Text] [Related]
4. Thiotepa-based conditioning versus total body irradiation as myeloablative conditioning prior to allogeneic stem cell transplantation for acute lymphoblastic leukemia: A matched-pair analysis from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Eder S; Canaani J; Beohou E; Labopin M; Sanz J; Arcese W; Or R; Finke J; Cortelezzi A; Beelen D; Passweg J; Socié G; Gurman G; Aljurf M; Stelljes M; Giebel S; Mohty M; Nagler A
Am J Hematol; 2017 Oct; 92(10):997-1003. PubMed ID: 28614903
[TBL] [Abstract][Full Text] [Related]
5. Irradiation free conditioning regimen is associated with high relapse rate in Egyptian patients with acute lymphoblastic leukemia following allogeneic hematopoietic stem cell transplantation.
Abdelaty MM; Gawaly A; Fathy GM; Kabbash I; Taha A
J Egypt Natl Canc Inst; 2020 Jun; 32(1):28. PubMed ID: 32537680
[TBL] [Abstract][Full Text] [Related]
6. Fludarabine or cyclophosphamide in combination with total body irradiation as myeloablative conditioning prior to allogeneic hematopoietic cell transplantation for acute lymphoblastic leukemia: an analysis by the Acute Leukemia Working Party of the EBMT.
Giebel S; Labopin M; Socié G; Aljurf M; Salmenniemi U; Labussière-Wallet H; Srour M; Kröger N; Zahrani MA; Lioure B; Reményi P; Arat M; Bourhis JH; Helbig G; Tbakhi A; Forcade E; Huynh A; Brissot E; Spirydonidis A; Savani BN; Peric Z; Nagler A; Mohty M
Bone Marrow Transplant; 2023 May; 58(5):506-513. PubMed ID: 36725978
[TBL] [Abstract][Full Text] [Related]
7. A comparison of cyclophosphamide and total body irradiation with etoposide and total body irradiation as conditioning regimens for patients undergoing sibling allografting for acute lymphoblastic leukemia in first or second complete remission.
Marks DI; Forman SJ; Blume KG; Pérez WS; Weisdorf DJ; Keating A; Gale RP; Cairo MS; Copelan EA; Horan JT; Lazarus HM; Litzow MR; McCarthy PL; Schultz KR; Smith DD; Trigg ME; Zhang MJ; Horowitz MM
Biol Blood Marrow Transplant; 2006 Apr; 12(4):438-53. PubMed ID: 16545728
[TBL] [Abstract][Full Text] [Related]
8. Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.
Mengarelli A; Iori A; Guglielmi C; Romano A; Cerretti R; Torromeo C; Micozzi A; Fenu S; Laurenti L; Donato V; De Felice L; Arcese W
Haematologica; 2002 Jan; 87(1):52-8. PubMed ID: 11801465
[TBL] [Abstract][Full Text] [Related]
9. Allogeneic hematopoietic stem-cell transplantation for acute myeloid leukemia in remission: comparison of intravenous busulfan plus cyclophosphamide (Cy) versus total-body irradiation plus Cy as conditioning regimen--a report from the acute leukemia working party of the European group for blood and marrow transplantation.
Nagler A; Rocha V; Labopin M; Unal A; Ben Othman T; Campos A; Volin L; Poire X; Aljurf M; Masszi T; Socie G; Sengelov H; Michallet M; Passweg J; Veelken H; Yakoub-Agha I; Shimoni A; Mohty M
J Clin Oncol; 2013 Oct; 31(28):3549-56. PubMed ID: 23980086
[TBL] [Abstract][Full Text] [Related]
10. Fludarabine, busulfan, and low-dose TBI conditioning versus cyclophosphamide and TBI in allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia.
Speziali C; Daly A; Abuhaleeqa M; Nitta J; Abou Mourad Y; Seftel MD; Paulson K
Leuk Lymphoma; 2019 Mar; 60(3):639-648. PubMed ID: 30160568
[TBL] [Abstract][Full Text] [Related]
11. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
12. Efficacy of etoposide, cyclophosphamide, and total body irradiation in allogeneic bone marrow transplantation for adult patients with hematological malignancies.
Toubai T; Tanaka J; Mori A; Hashino S; Kobayashi S; Ota S; Miura Y; Kato N; Kahata K; Izumiyama K; Yonezumi M; Chiba K; Kondo T; Toyoshima N; Asaka M; Imamura M
Clin Transplant; 2004 Oct; 18(5):552-7. PubMed ID: 15344959
[TBL] [Abstract][Full Text] [Related]
13. Comparison of total body irradiation plus cyclophosphamide with busulfan plus cyclophosphamide as conditioning regimens in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplant.
Eroglu C; Pala C; Kaynar L; Yaray K; Aksozen MT; Bankir M; Zararsız G; Orhan O; Gündog M; Yıldız OG; Eser B; Cetin M; Unal A
Leuk Lymphoma; 2013 Nov; 54(11):2474-9. PubMed ID: 23442062
[TBL] [Abstract][Full Text] [Related]
14. Outcome of medium-dose VP-16/CY/TBI superior to CY/TBI as a conditioning regimen for allogeneic stem cell transplantation in adult patients with acute lymphoblastic leukemia.
Shigematsu A; Tanaka J; Suzuki R; Atsuta Y; Kawase T; Ito YM; Yamashita T; Fukuda T; Kumano K; Iwato K; Yoshiba F; Kanamori H; Kobayashi N; Fukuhara T; Morishima Y; Imamura M
Int J Hematol; 2011 Nov; 94(5):463-71. PubMed ID: 22042561
[TBL] [Abstract][Full Text] [Related]
15. A myeloablative conditioning regimen for patients with impaired cardiac function undergoing allogeneic stem cell transplantation: reduced cyclophosphamide combined with etoposide and total body irradiation.
Yoshimi A; Nannya Y; Sakata-Yanagimoto M; Oshima K; Takahashi T; Kanda Y; Motokura T; Chiba S; Kurokawa M
Am J Hematol; 2008 Aug; 83(8):635-9. PubMed ID: 18506704
[TBL] [Abstract][Full Text] [Related]
16. A comparative study of outcomes of idarubicin- and etoposide-intensified conditioning regimens for allogeneic peripheral blood stem cell transplantation in patients with high-risk acute leukemia.
Li QB; Li L; You Y; Chen ZC; Xia LH; Zou P
Acta Pharmacol Sin; 2009 Oct; 30(10):1471-8. PubMed ID: 19767767
[TBL] [Abstract][Full Text] [Related]
17. Impact of Conditioning Regimen on Outcomes for Children with Acute Myeloid Leukemia Undergoing Transplantation in First Complete Remission. An Analysis on Behalf of the Pediatric Disease Working Party of the European Group for Blood and Marrow Transplantation.
Lucchini G; Labopin M; Beohou E; Dalissier A; Dalle JH; Cornish J; Zecca M; Samarasinghe S; Gibson B; Locatelli F; Bertrand Y; Abdel-Rahman F; Socie G; Sundin M; Lankester A; Sedlacek P; Hamladji RM; Heilmann C; Afanasyev B; Hough R; Peters C; Bader P; Veys P
Biol Blood Marrow Transplant; 2017 Mar; 23(3):467-474. PubMed ID: 27916512
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes of total body irradiation plus cyclophosphamide versus busulfan plus cyclophosphamide as conditioning regimen for acute lymphoblastic leukemia: a comparative study.
Sakellari I; Gavriilaki E; Chatziioannou K; Papathanasiou M; Mallouri D; Batsis I; Bousiou Z; Bouziana S; Constantinou V; Douka V; Apostolou C; Iskas M; Lalayanni C; Athanasiadou A; Sotiropoulos D; Yannaki E; Gianouzakos V; Anagnostopoulos A
Ann Hematol; 2018 Oct; 97(10):1987-1994. PubMed ID: 29869673
[TBL] [Abstract][Full Text] [Related]
19. Overcoming minimal residual disease using intensified conditioning with medium-dose etoposide, cyclophosphamide and total body irradiation in allogeneic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults.
Harada K; Morita-Fujita M; Fukuda T; Ozawa Y; Doki N; Toyosaki M; Maruyama Y; Kanda Y; Ashida T; Eto T; Takada S; Uchida N; Ichinohe T; Kanda J; Onizuka M; Atsuta Y; Kako S; Arai Y
Cytotherapy; 2022 Sep; 24(9):954-961. PubMed ID: 35534419
[TBL] [Abstract][Full Text] [Related]
20. Allo-HSCT for acute leukemia of ambiguous lineage in adults: the comparison between standard conditioning and intensified conditioning regimens.
Liu QF; Fan ZP; Wu MQ; Sun J; Wu XL; Xu D; Jiang QL; Zhang Y; Huang F; Wei YQ; Zhao J; Yu GP; Meng FY
Ann Hematol; 2013 May; 92(5):679-87. PubMed ID: 23274355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
